3,3-Bis(trifluoromethyl)-3-hydroxypropionic acid, 97.0%, 5g

(2,3,4,5-Tetrafluorophenyl)boronic acid, 95+%, 10g

6-(Hydroxymethyl)picolinic acid, 95.0%, 250mg

4-((4-(Benzyloxy)phenyl)sulfonyl)phenol, 95.0%, 25g

4-Methyl-4-(methyldisulfanyl)pentanoic acid, 98%, 50mg

methyl (3R,4R)-4-methylpyrrolidine-3-carboxylate hydrochloride, 97.0%, 1g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-(phenylmethyl)-L-histidine, 97%, 1g

2-Chloro-3-(4-methylpiperazin-1-yl)quinoxaline, 95.0%, 10mg

(E)-Methyl 4-(4-bromophenyl)-2-oxobut-3-enoate, 95.0%, 1g

DL-Glutamine, 95.0%, 1g

5-Benzyl-2-hydroxy-benzaldehyde, 250mg

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Neu5Ac alpha(2-6)GalNAc-alpha-pNP>98.0%(HPLC)5mg